Therapeutic whole blood exchange using plasma exchange kit on a cell separator in a patient with refractory methemoglobinemia

2020 ◽  
Vol 59 (6) ◽  
pp. 102910
Author(s):  
Bala Bhasker ◽  
Anamika Aluri ◽  
Ramakrishna
Transfusion ◽  
2020 ◽  
Vol 60 (3) ◽  
pp. 449-453 ◽  
Author(s):  
David Ming‐Hung Lin ◽  
Joanne Becker ◽  
YanYun Wu ◽  
Laura Cooling
Keyword(s):  

2000 ◽  
Vol 46 (9) ◽  
pp. 1387-1394 ◽  
Author(s):  
Jochen Reinsberg ◽  
Jörg Dembinski ◽  
Christoph Dorn ◽  
Daniela Behrendt ◽  
Peter Bartmann ◽  
...  

Abstract Background: It has been shown that a high percentage of interleukin-8 (IL-8) in blood is cell associated. Recently, a simple method for determination of cell-associated IL-8 in whole blood after cell lysis has been described. The purpose of this study was to evaluate this method, to examine the influence of preanalytic sample handling, and to establish the concentration range of total IL-8 and its relation to age and sex in healthy subjects. Methods: Total IL-8 content of whole blood was determined after lysing blood cells with Milenia® cell lysis solution. IL-8 in the resulting blood lysate was measured with the IMMULITE® IL-8 immunoassay. Results: When freshly drawn blood was stored up to 48 h on ice, no significant changes in total IL-8 were measured in the subsequently prepared lysate, whereas with storage at room temperature, total IL-8 increased after 3 h from 94 ± 13 ng/L to 114 ± 16 ng/L (n = 10). In lysate stored for 48 h at 4 °C, marginal changes of the IL-8 concentration were noted, with storage at room temperature, only 76% ± 5% (n = 12) of initial concentration was recovered. From lysate frozen at −20 and −80 °C, respectively, 84% ± 4% and 93% ± 2% of initial IL-8 was recovered after 70 days (n = 10). IL-8 was measured with comparable precision in plasma (CV, 3.2–4.2%) and blood lysate (CV, 3.7–4.1%). When plasma was diluted with cell lysis solution, a slightly overestimated recovery (125% ± 3%) was observed; for lysate specimens with a cell lysis solution content ≥75%, the recovery after dilution was 98% ± 2%. In lysate prepared from 12 blood samples with exogenous IL-8 added, IL-8 recovery was 104% ± 2% (recovery from plasma <35%). The median total IL-8 in blood lysates from 103 healthy subjects (22–61 years) was 83 ng/L of blood (2.5–97.5 percentile range, 49–202 ng/L of blood). In females but not in males, total IL-8 increased significantly with advancing age (P <0.002). We found grossly increased total IL-8 in six pregnant women with amniotic infection syndrome. Conclusions: The evaluated method allows the assessment of total IL-8 in blood with good performance when appropriate conditions of sample pretreatment are considered. The values in healthy volunteers all were above the detection limit of the IL-8 assay; therefore, slight changes of total IL-8 could be noted. Thus, the present method is a suitable tool to study the diagnostic relevance of total IL-8 in blood.


1981 ◽  
Vol 7 (01) ◽  
pp. 25-32 ◽  
Author(s):  
Jerome Gottschall ◽  
Anthony Pisciotta ◽  
Joseph Darin ◽  
Clara Hussey ◽  
Richard Aster

Blood ◽  
2012 ◽  
Vol 120 (21) ◽  
pp. 4842-4842
Author(s):  
Burgund Kauling ◽  
Volker Huppert ◽  
Stephanie Soltenborn ◽  
Angela Hillenkötter ◽  
Mariette Mohaupt ◽  
...  

Abstract Abstract 4842 Obtaining pure and unaffected leukocyte populations is of utmost importance in diagnostic as well as research settings. So far, the isolation of functional leukocyte subpopulations from whole blood has been a time-consuming procedure, rendering the performance of downstream assays and analyses a challenging objective. We have developed a cell isolation technology that allows the purification of immune cells from human whole blood within 20 minutes. This novel technology requires a minimum of laboratory equipment. A cell isolation reagent is added to the anticoagulated blood sample and mixed briefly. While placed in a strong magnetic field, magnetically labeled non-target cells are depleted, while untouched target cells remain in the supernatant. Simultaneously, a reagent-assisted erythrocyte sedimentation phase occurs, which depletes ∼99.7 % of erythrocytes. Using this novel technology, Natural Killer cells, B cells, T cells, CD4+ T helper cells, CD8+ cytotoxic T cells and naïve B cells were isolated from 30mL of anticoagulated human whole blood. Target cells were recovered in a volume of 25–30 mL of supernatant (67% plasma, 33% Phosphate buffered saline) and average purities among white blood cells were 88.9% for NK cells, 88.2% for B cells, 97.8% for T cells, 93.0% for CD4+ cells, 78.9% for CD8+ T cells and 79.4% for naïve B cells, yields were 75.5%, 84.4%, 54.5%, 63.0%, 59.5% and 96.8% respectively (n >6 each). Red Blood cells were reduced by ∼99.7%, platelets by >99.9%. Cytotoxicity and proliferative capacity of isolated NK cells were measured in cytotoxicity assays with K562 target cells and proliferation assays with antibody loaded large magnetic beads respectively. Cytotoxicity and proliferation rate were comparable to those assessed using NK cells isolated by Ficoll density gradient separation or magnetic cell sorting (NK cell isolation kit). In vitro proliferation assays with total T cells, CD4+ T cells, CD8+ T cells or B cells revealed that proliferation rate was identical to that of target cells which were isolated by Ficoll density gradient separation and magnetic cell sorting. We furthermore compared the mRNA yields from cells isolated with either method (new technology vs. Miltenyi's isolation kits). The mRNA samples were subsequently subjected to gene expression analysis. Comparing the results obtained from samples isolated with the two different separation methods, we could not detect any significant differences in gene expression levels. These results demonstrate, that cells isolated with the novel whole blood cell isolation strategy, can be used for cell-based functional assays, as well as gene expression profiling. Additionally, overall processing time can be significantly reduced, which is highly desirable for sensitive downstream experiments. Disclosures: Kauling: Miltenyi Biotec GmbH: Employment. Huppert:Miltenyi Biotec GmbH: Employment. Soltenborn:Miltenyi Biotec GmbH: Employment. Hillenkötter:Miltenyi Biotec GmbH: Employment. Mohaupt:Miltenyi Biotec GmbH: Employment. Schmitz:Miltenyi Biotec GmbH: Employment.


2001 ◽  
Vol 8 (1) ◽  
pp. 9-13 ◽  
Author(s):  
Hyeong-soon Shin ◽  
Chang-kyu Kim ◽  
Kwang-soon Shin ◽  
Hong-keun Chung ◽  
Tae-ryeon Heo

ABSTRACT Immunochromatographic assays (ICAs) are also referred to as rapid tests, since they are simple and the results can be obtained within minutes after manually loading a few drops of a sample into each sample well of the test device. However, whole blood cannot be tested with ICA kits due to the visual hindrance caused by the color of red blood cells (RBCs), unless a cell-removing device such as a filter is mounted on the kits. Thus, when testing with blood, the advantage of the ICA kit is lost because of the additional time and machines required to coagulate and separate whole blood before preparing the serum. To overcome this limitation, whole-blood samples were added to a pretreatment solution to decolor the RBCs; the resulting mixtures were then loaded into the sample wells of the test device. The pretreating solution was composed of hydrogen peroxide (H2O2) to decolor the RBCs, Sag 471 (Osi Specialties) to restrain the mixture from vigorous foaming, sodium azide (NaN3) to inhibit the enzyme, which generates excessive foam at the beginning of decolorization, and EDTA as a chelating agent. As a result of this pretreatment, whole blood could be used with the ICA kit without reducing its simplicity and rapidity.


Sign in / Sign up

Export Citation Format

Share Document